Texas Oncology

Fort Worth, Texas 76104

1 studies enrolling now · 25 studies all time

What they study most

ARID1A Gene Mutation, Advanced Breast Cancer, Advanced Solid Tumor, Advanced Solid Tumors, Breast Cancer, Cancer, Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate, Carcinoma, Non-Small Cell Lung, Castration-resistant Prostate Cancer, Cervical Cancer, Chronic Lymphocytic Leukemia, Colorectal Cancer

Studies at this site

• A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer — Recruiting now
• A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma — Recruiting now
• A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer — Stopped early
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) — Running, not enrolling
• Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian — Completed
• Palbociclib in Real World Practice — Completed
• A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors — Stopped early
• Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100) — Stopped early
• TAC Versus TC for Adjuvant Breast Cancer — Completed
• Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLC — Completed
• Impact of Five Love Languages on Cancer Patients — Status unconfirmed
• Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer — Completed
• A Phase I, Bioequivalence Study to Evaluate Two Formulations of Bendamustine (BDM) Hydrochloride (HCl) Administered to Cancer Patients — Completed
• A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Study of SY-1365 in Adult Patients With Advanced Solid Tumors — Stopped early
• A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma — Completed
• A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer — Stopped early
• Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela ) — Completed
• Gemzar, Cisp, Sunitinib Urothelial Ca — Completed
• Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic — Completed
• Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer — Completed
• Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer — Completed
• Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer — Completed
• Clinical Trial for Ovarian Cancer (OvaRex®) — Stopped early
• A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer — Completed